LynxDx Acquires Integra Biosciences’ Pipettes To Combat Prostate Cancer
ANN ARBOR - LynxDx, an Ann Arbor diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to









